RITUXIMAB

97040 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB:

# Side effect Count
0 DRUG INEFFECTIVE 16579
1 RHEUMATOID ARTHRITIS 8830
2 OFF LABEL USE 8605
3 PAIN 5957
4 FATIGUE 5801
5 NAUSEA 4973
6 ARTHRALGIA 4739
7 DRUG INTOLERANCE 4654
8 NEUTROPENIA 4479
9 PNEUMONIA 4413
See all common reactions for RITUXIMAB

RITUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 283 0.6675
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 572 0.6560
2 RED BLOOD CELL SEDIMENTATION RATE 69 0.6389
3 MANTLE CELL LYMPHOMA RECURRENT 111 0.6201
4 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 155 0.6102
5 B-CELL LYMPHOMA RECURRENT 228 0.6032
6 PEMPHIGUS 1670 0.5986
7 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 443 0.5687
8 GRANULOMA SKIN 231 0.5347
9 LYMPHOMA TRANSFORMATION 71 0.4897
See all enriched reactions for RITUXIMAB